ArticleSurgical endoscopy2026
Understanding the perioperative morbidity associated with concomitant transversus abdominis release in retromuscular ventral hernia repair: a retrospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe need for ventral hernia repair is becoming increasingly prevalent, and there is a need for analysis of surgical techniques and their associated risks. We aimed to characterize the perioperative morbidity associated with robotic extended totally extraperitoneal (eTEP) hernia repair with concomitant transversus abdominis release (TAR), particularly in the context of more complex ventral hernias.
methodsThis retrospective study analyzed outcomes of patients undergoing eTEP hernia repair, stratified into two groups: those undergoing concomitant TAR and those without TAR at a single institution. Baseline demographics, hernia characteristics, intraoperative details, and postoperative complications were collected.
resultsMean operative time was significantly longer in the TAR group (254 [187.25, 320.75] min vs. 198.5 [149.88, 247.12] min, p < 0.001), as were intraoperative length (5 [3.5, 6.5] cm vs. 4 [3, 5] cm, p < 0.001) and mesh dimensions (mesh length: 30 [25, 35] cm vs. 20 [12.5, 27.5] cm, p < 0.001; mesh width: 30 [25, 35] cm vs. 15 [7.5, 22.5] cm, p < 0.001). Adhesiolysis greater than 45 min (18.5% vs. 1.8%, p < 0.001) and drain use (50.8% vs. 30.9%, p < 0.001) were more frequent in the TAR group. While overall 30-day complications were similar (7.7% vs. 4.5%, p = 0.4), surgical site infections (SSI) were significantly higher in the TAR group (7.7% vs. 0.9%, p = 0.04). Postoperative pain was also reported more frequently in the TAR group (36.9% vs. 24.5%, p = 0.03).
conclusioneTEP TAR may be associated with incremental perioperative morbidity, reflecting its use in more complex hernia repairs, but can be an excellent tool for appropriately selected patients with more complex hernias and associated comorbidities, as shown in our sample. Significant surgeon expertise and experience are recommended to perform this procedure, and recognition of this added morbidity is critical for appropriate patient selection and preoperative counseling, ensuring that TAR is reserved for cases in which its reconstructive benefits outweigh its risks.
Indexed as
Identifiers
42728435What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.